Daniela Simian
Overview
Explore the profile of Daniela Simian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
372
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vega L, Simian D, Gajardo A, Salinas M, Urra A, Cattaneo M, et al.
Ann Hepatol
. 2024 May;
29(4):101511.
PMID: 38710474
Introduction And Objectives: Patients with metabolic dysfunction-associated steatotic liver disease (MASLD) are at an increased cardiovascular risk. On the contrary, non-alcoholic fatty liver disease (NAFLD) is highly prevalent in patients...
2.
Chelech F, Marcel Bonilla J, Poniachik J, Urzua A, Simian D, Hurtado C
Rev Med Chil
. 2024 Apr;
151(4):461-468.
PMID: 38687521
Introduction: For the diagnosis of liver diseases, clinical criteria, biochemical, immunological and histological parameters are included. The autoimmune panel is an immunoblot that contemplates the detection of antibodies against 9...
3.
Salinas M, Simian D, Carreno L, Cattaneo M, Urzua A, Saure A, et al.
Rev Med Chil
. 2023 Jun;
150(11):1431-1437.
PMID: 37358168
Background: Cholangiocarcinoma (CCA) is a primary hepatic tumor, frequently found in patients with liver cirrhosis and biliary tract diseases. Its varieties include isolated CCA or "combined hepatocellular-cholangiocarcinoma" (cHCC-CCA). The latter...
4.
Mendizabal M, Thompson M, Gonzalez-Ballerga E, Anders M, Castro-Narro G, Pessoa M, et al.
J Viral Hepat
. 2022 Oct;
30(1):56-63.
PMID: 36197907
To achieve WHO's goal of eliminating hepatitis C virus (HCV), innovative strategies must be designed to diagnose and treat more patients. Therefore, we aimed to describe an implementation strategy to...
5.
Toledo P, Cardenas G, Berger Z, Simian D, Araya F
Turk J Gastroenterol
. 2022 Aug;
33(8):704-709.
PMID: 35946885
Background: To determine the effect of intramuscular administration of Neostigmine® on the visualization of the pancreatic duct on magnetic resonance cholangiopancreatography in patients with recurrent acute pancreatitis or abdominal pain....
6.
Landskron G, Dubois-Camacho K, Orellana-Serradell O, De la Fuente M, Parada-Venegas D, Bitran M, et al.
Cells
. 2022 Jun;
11(12).
PMID: 35741034
Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) and can be treated with glucocorticoids (GC), although some patients are unresponsive to this therapy. The transcription factor LRH-1/ is critical...
7.
Simian D, Martinez M, Dreyse J, Chomali M, Retamal M, Labarca G
J Bras Pneumol
. 2021 Sep;
47(4):e20210131.
PMID: 34495176
Objective: To describe baseline characteristics of outpatients with a positive RT-PCR for SARS-CoV-2 and to define whether "red flags" (new-onset fever, dyspnea, and chest pain) can predict clinical worsening during...
8.
Quera R, Simian D, Nunez P, Flores L
Dig Liver Dis
. 2021 Jun;
53(11):1519-1520.
PMID: 34148863
No abstract available.
9.
Nunez F P, Quera R, Sepulveda E, Simian D, Pizarro G, Lubascher J, et al.
Gastroenterol Hepatol
. 2021 Mar;
44(4):277-285.
PMID: 33745519
Background: In inflammatory bowel disease (IBD) a high percentage of women are diagnosed during their reproductive age. IBD in remission is the ideal scenario when planning a pregnancy. Aims: To...
10.
Perez de Arce E, Quera R, Nunez P, Simian D, Ibanez P, Lubascher J, et al.
Gastroenterol Hepatol
. 2021 Jan;
45(3):206-207.
PMID: 33388176
No abstract available.